서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 23 of 23

Issue DateTitle / Author(s) / CitationFileAltmetrics
2015-02
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

Lei, Jieping; Rudolph, Anja; Moysich, Kirsten B; Rafiq, Sajjad; Behrens, Sabine; Goode, Ellen L; Pharoah, Paul P; Seibold, Petra; Fasching, Peter A; Andrulis, Irene L; Kristensen, Vessela N; Couch, Fergus J; Hamann, Ute; Hooning, Maartje J; Nevanlinna, Heli; Eilber, Ursula; Bolla, Manjeet K; Dennis, Joe; Wang, Qin; Lindblom, Annika; Mannermaa, Arto; Lambrechts, Diether; García-Closas, Montserrat; Hall, Per; Chenevix-Trench, Georgia; Shah, Mitul; Luben, Robert; Haeberle, Lothar; Ekici, Arif B; Beckmann, Matthias W; Knight, Julia A; Glendon, Gord; Tchatchou, Sandrine; Alnæs, Grethe I G; Borresen-Dale, Anne-Lise; Nord, Silje; Olson, Janet E; Hallberg, Emily; Vachon, Celine; Torres, Diana; Ulmer, Hans-Ulrich; Rüdiger, Thomas; Jager, Agnes; van Deurzen, Carolien H; Tilanus-Linthorst, Madeleine M; Muranen, Taru A; Aittomäki, Kristiina; Blomqvist, Carl; Margolin, Sara; Kosma, Veli-Matti; Hartikainen, Jaana M; Kataja, Vesa; Hatse, Sigrid; Wildiers, Hans; Smeets, Ann; Figueroa, Jonine; Chanock, Stephen J; Lissowska, Jolanta; Li, Jingmei; Humphreys, Keith; Phillips, Kelly-Anne; Linn, Sabine; Cornelissen, Sten; van den Broek, Sandra A J; Kang, Daehee; Choi, Ji-Yeob; Park, Sue K; Yoo, Keun-Young; Hsiung, Chia-Ni; Wu, Pei-Ei; Hou, Ming-Feng; Shen, Chen-Yang; Teo, Soo H; Taib, Nur A M; Yip, Cheng H; Ho, Gwo F; Matsuo, Keitaro; Ito, Hidemi; Iwata, Hiroji; Tajima, Kazuo; Dunning, Alison M; Benitez, Javier; Czene, Kamila; Sucheston, Lara E; Maishman, Tom; Tapper, William J; Eccles, Diana; Easton, Douglas F; Schmidt, Marjanka K; Chang-Claude, Jenny

Breast Cancer Research, 17(1):18

view fileDOI
2015-02
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

Lei, Jieping; Rudolph, Anja; Moysich, Kirsten B; Rafiq, Sajjad; Behrens, Sabine; Goode, Ellen L; Pharoah, Paul P; Seibold, Petra; Fasching, Peter A; Andrulis, Irene L; Kristensen, Vessela N; Couch, Fergus J; Hamann, Ute; Hooning, Maartje J; Nevanlinna, Heli; Eilber, Ursula; Bolla, Manjeet K; Dennis, Joe; Wang, Qin; Lindblom, Annika; Mannermaa, Arto; Lambrechts, Diether; García-Closas, Montserrat; Hall, Per; Chenevix-Trench, Georgia; Shah, Mitul; Luben, Robert; Haeberle, Lothar; Ekici, Arif B; Beckmann, Matthias W; Knight, Julia A; Glendon, Gord; Tchatchou, Sandrine; Alnæs, Grethe I G; Borresen-Dale, Anne-Lise; Nord, Silje; Olson, Janet E; Hallberg, Emily; Vachon, Celine; Torres, Diana; Ulmer, Hans-Ulrich; Rüdiger, Thomas; Jager, Agnes; van Deurzen, Carolien H; Tilanus-Linthorst, Madeleine M; Muranen, Taru A; Aittomäki, Kristiina; Blomqvist, Carl; Margolin, Sara; Kosma, Veli-Matti; Hartikainen, Jaana M; Kataja, Vesa; Hatse, Sigrid; Wildiers, Hans; Smeets, Ann; Figueroa, Jonine; Chanock, Stephen J; Lissowska, Jolanta; Li, Jingmei; Humphreys, Keith; Phillips, Kelly-Anne; Linn, Sabine; Cornelissen, Sten; van den Broek, Sandra A J; Kang, Daehee; Choi, Ji-Yeob; Park, Sue K; Yoo, Keun-Young; Hsiung, Chia-Ni; Wu, Pei-Ei; Hou, Ming-Feng; Shen, Chen-Yang; Teo, Soo H; Taib, Nur A M; Yip, Cheng H; Ho, Gwo F; Matsuo, Keitaro; Ito, Hidemi; Iwata, Hiroji; Tajima, Kazuo; Dunning, Alison M; Benitez, Javier; Czene, Kamila; Sucheston, Lara E; Maishman, Tom; Tapper, William J; Eccles, Diana; Easton, Douglas F; Schmidt, Marjanka K; Chang-Claude, Jenny

Breast Cancer Research, 17(1):18

view fileDOI
2016-04
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
DOI
2017-07
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
DOI
2017-08
PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Therapy-Safety and Efficacy in Asian Patients
DOI
2017-09
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results
DOI
2018-03
Phase III, Randomized study of dual human epidermal growth factor receptor 2 (HER2) blockade with lapatinib plus trastuzumab in combination with an aromatase inhibitor in postmenopausal women with HER2-positive, hormone receptor-positive metastatic breast cancer: ALTERNATIVE
DOI
2018-11
Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2
DOI
2018-11
Overall survival with palbociclib and fulvestrant in advanced breast cancer
DOI
2019-01
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
DOI
2020-02
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
DOI
2020-05
Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis
DOI
2020-12
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
DOI
2021-01
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE
DOI
2021-06
Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2- advanced breast cancer: MONARCH 2 & 3 trials
DOI
2022-07
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
DOI
2022-08
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2(- )ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study
DOI
2023-01
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
DOI
2023-08
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
DOI
2023-11
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
DOI
2023-12
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

Balmana, Judith; Fasching, Peter A.; Couch, Fergus J.; Delaloge, Suzette; Labidi-Galy, Intidhar; O'Shaughnessy, Joyce; Park, Yeon Hee; Eisen, Andrea F.; You, Benoit; Bourgeois, Hughes; Goncalves, Anthony; Kemp, Zoe; Swampillai, Angela; Jankowski, Tomasz; Sohn, Joo Hyuk; Poddubskaya, Elena; Mukhametshina, Guzel; Aksoy, Sercan; Timcheva, Constanta V.; Park-Simon, Tjoung-Won; Anton-Torres, Antonio; John, Ellie; Baria, Katherine; Gibson, Isabel; Gelmon, Karen A.; Koynova, Tatyana; Popov, Vasil; Timcheva, Constanta; Tomova, Antoaneta; Eisen, Andrea; Gelmon, Karen; Lemieux, Julie; Augereau, Paule; Bazan, Fernando; Becuwe, Celia; Bourgeois, Hugues; Chakiba, Camille; Chehimi, Mohamad; Cheneau, Caroline; Dalenc, Florence; de Guillebon, Eleonore; de la Motte Rouge, Thibault; Frenel, Jean-Sebastien; Goncalves, Anthony; Grenier, Julien; Hardy-Bessard, Anne Claire; Lamy, Regine; Levy, Christelle; Lortholary, Alain; Mailliez, Audrey; Medioni, Jacques; Patsouris, Anne; Spaeth, Dominique; Teixeira, Luis; Tennevet, Isabelle; Venat-Bouvet, Laurence; Villanueva, Cristian; You, Benoit; Ettl, Johannes; Fasching, Peter; Gerber, Bernd; Hanusch, Claus Alexander; Hoffmann, Oliver; Park-Simon, Tjoung-Won; Malter, Wolfram; Reinisch, Mattea; Tio, Joke; Wimberger, Pauline; Boer, Katalin; Dank, Magdolna; Ballestrero, Alberto; Bianchini, Giampaolo; Biganzoli, Laura; Bordonaro, Roberto; Cognetti, Francesco; Cortesi, Enrico; De Laurentiis, Michelino; De Placido, Sabino; Gianni, Luca; Guarneri, Valentina; Marchetti, Paulo; Montemurro, Filippo; Mosconi, Anna Maria; Naso, Giuseppe; Puglisi, Fabio; Santoro, Armando; Zamagni, Claudio; Iwata, Hiroji; Kim, Seung-Jin; Nakamura, Seigo; Chae, Yee Soo; Cho, Eun Kyung; Kim, Jee Hyun; Im, Seock-Ah; Lee, Keun Seok; Park, Yeon Hee; Sohn, Joo Hyuk; Byrski, Tomasz; Huzarski, Tomasz; Jankowski, Tomasz; Kukielka-Budny, Bozena; Lacko, Aleksandra; Nowecki, Zbigniew; Senkus-Konefka, Elzbieta; Szoszkiewicz, Renata; Tarnawski, Rafal; Andabekov, Timur; Dvorkin, Mikhail; Dvornichenko, Viktoria; Moiseenko, Fedor; Mukhametshina, Guzel; Poddubskaya, Elena; Popova, Ekaterina; Tarasova, Anna; Sakaeva, Dina; Shomova, Marina; Vats, Anna; Adamo, Barbara; Conejero, Raquel Andres; Torres, Antonio Anton; Gelpi, Judith Balmana; de Ibarguen, Blanca Cantos Sanchez; Jurado, Josefina Cruz; Fernandez, Nieves Diaz; Gonzalez, Alejandro Falcon; Garcia, Juan; Santiago, Santiago Gonzalez; Carrasco, Fernando Henao; Lorenzo, Isabel Lorenzo; Anton, Fernando Moreno; Garcia, Beatriz Rojas; Beltran, Salomon Menjon; Santisteban, Marta; Stradella, Agostina; Hou, Ming-Feng; Huang, Chiun-Sheng; Lin, Yung-Chang; Tseng, Ling-Ming; Wang, Hwei-Chung; Aksoy, Sercan; Arslan, Cagatay; Artac, Mehmet; Aydiner, Adnan; Disel, Umut; Ozkan, Metin; Ozyilkan, Ozgur; Sezer, Emel Yaman; Yetisyigit, Tarkan; Armstrong, Anne; Barrett, Sophie; Borley, Annabel; Kemp, Zoe; Michie, Caroline; Mukesh, Mukesh; Perren, Timothy; Swampillai, Angela; Chaudhry, Madhu; Young, Tammy

BREAST CANCER RESEARCH AND TREATMENT

DOI
Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355
DOI
Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2-expressing salivary gland carcinoma: a pooled analysis of two phase I studies
DOI
1